NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) — Marex Group plc (“Marex”), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at $19.00 per share. A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Marex will not receive any proceeds from any sale of shares by the Selling Shareholders. The ordinary shares are expected to begin trading on the Nasdaq Global Select Market on April 25, 2024, under the ticker symbol “MRX.” The offering is expected to close on April 29, 2024, subject to customary closing conditions.

In connection with the offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 2,307,692 ordinary …

Full story available on Benzinga.com

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) — Marex Group plc (“Marex”), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at $19.00 per share. A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Marex will not receive any proceeds from any sale of shares by the Selling Shareholders. The ordinary shares are expected to begin trading on the Nasdaq Global Select Market on April 25, 2024, under the ticker symbol “MRX.” The offering is expected to close on April 29, 2024, subject to customary closing conditions.

In connection with the offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 2,307,692 ordinary …

Full story available on Benzinga.com

 NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) — Marex Group plc (“Marex”), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at $19.00 per share. A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Marex will not receive any proceeds from any sale of shares by the Selling Shareholders. The ordinary shares are expected to begin trading on the Nasdaq Global Select Market on April 25, 2024, under the ticker symbol “MRX.” The offering is expected to close on April 29, 2024, subject to customary closing conditions.
In connection with the offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 2,307,692 ordinary …Full story available on Benzinga.com   Read MoreMRX, News, IPOs, Press Releases IPOs